IBB vs VFH
iShares Biotechnology ETF vs Vanguard Financials ETF
- • VFH has the lower expense ratio at 0.09% vs 0.44% for IBB.
- • VFH pays a higher dividend yield (1.77%).
Side-by-side metrics
| Metric | IBB | VFH |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.22% | 1.77% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $13.81B |
YTD return | 16.44% | 1.73% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 0.83 |
P/E ratio | 24.89 | 16.76 |
Last price | $197.34 | $135.99 |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
VFH top holdings
| JPM | JPMorgan Chase & Co | 8.83% |
| BRK-B | Berkshire Hathaway Inc Class B | 7.77% |
| MA | Mastercard Inc Class A | 4.76% |
| BAC | Bank of America Corp | 4.13% |
| V | Visa Inc Class A | 4.10% |
| GS | The Goldman Sachs Group Inc | 3.38% |
| MS | Morgan Stanley | 2.90% |
| WFC | Wells Fargo & Co | 2.80% |
| C | Citigroup Inc | 2.39% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VFH
VFH (Vanguard Financials ETF) is US financial services sector stocks. Managed by Vanguard, the fund carries $13.8B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.77%. Its largest holding is JPMorgan Chase & Co (JPM), which represents 8.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.8%.